Federated Hermes’s Prelude Therapeutics PRLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-65
| Closed | -$393 | – | 2227 |
|
|
2022
Q4 | $393 | Sell |
65
-1,342
| -95% | -$8.11K | ﹤0.01% | 2097 |
|
|
2022
Q3 | $9K | Buy |
1,407
+1,141
| +429% | +$7.3K | ﹤0.01% | 1844 |
|
|
2022
Q2 | $1K | Buy |
+266
| New | +$1K | ﹤0.01% | 2070 |
|
|
2021
Q4 | – | Sell |
-408,100
| Closed | -$12.8M | – | 2285 |
|
|
2021
Q3 | $12.8M | Buy |
408,100
+72,000
| +21% | +$2.25M | 0.02% | 586 |
|
|
2021
Q2 | $9.62M | Hold |
336,100
| – | – | 0.02% | 673 |
|
|
2021
Q1 | $14.6M | Buy |
336,100
+186,100
| +124% | +$8.06M | 0.03% | 569 |
|
|
2020
Q4 | $10.7M | Hold |
150,000
| – | – | 0.02% | 624 |
|
|
2020
Q3 | $4.52M | Buy |
+150,000
| New | +$4.52M | 0.01% | 753 |
|